Amor and colleagues previously developed chimeric antigen receptor (CAR) T cells that can target and eliminate senescent cells. The utility of these senolytic CAR T cells is now expanded to show that they can combat age-related metabolic dysfunction, and that they can be used prophylactically and have effects that persist for months, thus opening the door to the development of long-term senolytic approaches.
References
Xu, M. et al. Nat. Med. 24, 1246–1256 (2018).
Xu, M. et al. eLife 4, e12997 (2015).
Gasek, N. S., Kuchel, G. A., Kirkland, J. L. & Xu, M. Nat. Aging 1, 870–879 (2021).
Amor, C. et al. Nat. Aging https://doi.org/10.1038/s43587-023-00560-5 (2024).
Amor, C. et al. Nature 583, 127–132 (2020).
Aguayo-Mazzucato, C. et al. Cell Metab. 30, 129–142.e4 (2019).
Wang, L. et al. Cell Metab. 34, 75–89.e8 (2022).
Yi, H. S. et al. Cell Death Dis. 10, 249 (2019).
Cohn, R. L., Gasek, N. S., Kuchel, G. A. & Xu, M. Trends Cell Biol. 33, 9–17 (2023).
Chaib, S., Tchkonia, T. & Kirkland, J. L. Nat. Med. 28, 1556–1568 (2022).
Mitra, A. et al. Front. Immunol. 14, 1188049 (2023).
Baker, D. J., Arany, Z., Baur, J. A., Epstein, J. A. & June, C. H. Nature 619, 707–715 (2023).
Yang, D. et al. Sci. Transl. Med. 15, eadd1951 (2023).
Labanieh, L. & Mackall, C. L. Nature 614, 635–648 (2023).
Acknowledgements
This work was supported in part by NIH grants R01AG076642 (M.X.), R01AG066679 (M.X.), U54AG079753 (M.X.), and R01AI173305 (J.M.B.).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Bartley, J.M., Xu, M. Unleashing CAR T cells to delay metabolic aging. Nat Aging 4, 284–286 (2024). https://doi.org/10.1038/s43587-024-00576-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43587-024-00576-5
- Springer Nature America, Inc.